X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (95) 95
index medicus (94) 94
hematology (66) 66
male (55) 55
female (53) 53
adult (51) 51
aged (49) 49
middle aged (48) 48
oncology (31) 31
leukemia (16) 16
aged, 80 and over (15) 15
treatment outcome (15) 15
prognosis (14) 14
adolescent (12) 12
medicine & public health (12) 12
expression (11) 11
leukemia, myeloid, acute - pathology (10) 10
cancer (9) 9
leukemia, myeloid, acute - genetics (9) 9
medical colleges (9) 9
mutation (9) 9
p-glycoprotein (9) 9
polymerase chain reaction (9) 9
therapy (9) 9
acute lymphoblastic-leukemia (8) 8
acute myeloid-leukemia (8) 8
antineoplastic agents - therapeutic use (8) 8
blast crisis (8) 8
myelodysplastic syndrome (8) 8
young adult (8) 8
abridged index medicus (7) 7
acute disease (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
chronic myelogenous leukemia (7) 7
chronic myeloid leukemia (7) 7
drug resistance, neoplasm (7) 7
flow cytometry (7) 7
hematology, oncology and palliative medicine (7) 7
leukemia, myeloid, acute - drug therapy (7) 7
lymphomas (7) 7
myelodysplastic syndromes (7) 7
myelodysplastic syndromes - genetics (7) 7
phenotype (7) 7
remission induction (7) 7
acute myeloid leukemia (6) 6
analysis (6) 6
antigens, cd - analysis (6) 6
benzamides (6) 6
cell division (6) 6
cell division - drug effects (6) 6
differentiation (6) 6
disease-free survival (6) 6
dose-response relationship, drug (6) 6
gene-expression (6) 6
growth (6) 6
imatinib mesylate (6) 6
immunohistochemistry (6) 6
karyotyping (6) 6
leukemia, myeloid - genetics (6) 6
leukemia, myeloid, acute - metabolism (6) 6
molecular sequence data (6) 6
proteins (6) 6
recombinant proteins - pharmacology (6) 6
rituximab (6) 6
survival rate (6) 6
tumor cells, cultured (6) 6
abl tyrosine kinase (5) 5
acute myeloblastic-leukemia (5) 5
acute myelogenous leukemia (5) 5
antineoplastic agents - pharmacology (5) 5
base sequence (5) 5
blotting, southern (5) 5
bone marrow - pathology (5) 5
case report (5) 5
cell line, tumor (5) 5
chronic myeloid-leukemia (5) 5
classification (5) 5
dna-binding proteins - genetics (5) 5
drug resistance, multiple (5) 5
hemic and lymphatic diseases (5) 5
identification (5) 5
induction (5) 5
leukocytes (5) 5
lung resistance-related protein (5) 5
malignant lymphoma (5) 5
medical research (5) 5
medicine, experimental (5) 5
nuclear proteins - genetics (5) 5
phosphorylation (5) 5
tumor stem cell assay (5) 5
vincristine - administration & dosage (5) 5
acute lymphoblastic leukemia (4) 4
anemia (4) 4
animals (4) 4
antigens, neoplasm - genetics (4) 4
apoptosis (4) 4
apoptosis - drug effects (4) 4
atp-binding cassette, sub-family b, member 1 - genetics (4) 4
biochemistry & molecular biology (4) 4
blood (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 04/2012, Volume 70 Suppl 2, p. 19
Journal Article
Haematologica, ISSN 0390-6078, 06/2012, Volume 97, Issue 6, pp. 903 - 906
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 2012, Volume 70, pp. 19 - 25
Journal Article
International Journal of Hematology, ISSN 0925-5710, 7/2014, Volume 100, Issue 1, pp. 88 - 95
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, pp. e80088 - e80088
L265P mutation in the MYD88 gene has recently been reported in Waldenstrom's macroglobulinemia; however the incidence has been different according to the... 
LYMPHOMAS | BCR | MULTIDISCIPLINARY SCIENCES | TIME | KAPPA-B | CARCINOMA | SOMATIC MUTATIONS | Humans | Middle Aged | Myeloid Differentiation Factor 88 - genetics | Lymphoma - genetics | Genotype | Male | Polymerase Chain Reaction | Adult | Female | Aged | Mutation | Multiple Myeloma - genetics | Waldenstrom Macroglobulinemia - genetics | Index Medicus
Journal Article
[Rinshō ketsueki] The Japanese journal of clinical hematology, ISSN 0485-1439, 10/2010, Volume 51, Issue 10, pp. 1428 - 1436
Journal Article
European Journal of Haematology, ISSN 0902-4441, 05/2017, Volume 98, Issue 5, pp. 467 - 477
ObjectivesWe previously reported loss of heterozygosity on 1p in chronic myelogenous leukemia (CML). We analyzed promoter methylation and mutation of tumor... 
myeloproliferative neoplasms | molecular cytogenetics | METHYLTRANSFERASE SUPERFAMILY | RIZ1 | P73 GENE | MYELODYSPLASTIC SYNDROME | RETINOBLASTOMA PROTEIN | ACUTE LYMPHOBLASTIC-LEUKEMIA | CHRONIC MYELOCYTIC-LEUKEMIA | MYELOID-LEUKEMIA | ALLELIC LOSS | HUMAN CANCERS | HEMATOLOGY | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Tumor Protein p73 - genetics | Male | DNA Methylation | Chromosomes, Human, Pair 1 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis | Karyotyping | Polymerase Chain Reaction | Adult | Female | Nuclear Proteins - genetics | Genes, Tumor Suppressor | Promoter Regions, Genetic | Genetic Predisposition to Disease | Histone-Lysine N-Methyltransferase - genetics | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Sequence Analysis, DNA | Cell Line, Tumor | Core Binding Factor Alpha 3 Subunit - genetics | Aged | Mutation | Neoplasm Staging | Azacytidine | RNA-directed DNA polymerase | Myeloid leukemia | Leukemia | Chronic myeloid leukemia | Blast | Chromosome 1 | Heterozygosity | Polymerase chain reaction | Demethylation | Loss of heterozygosity | DNA methylation | Tumor suppressor genes | Trichostatin A | Blast crisis | Methylation | Runx3 protein | Conformation | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, p. e80088
L265P mutation in the MYD88 gene has recently been reported in Waldenström’s macroglobulinemia; however the incidence has been different according to the... 
Immunoglobulin M | Phosphorylation | Disease | Leukemia | Immunoglobulin G | Multiple myeloma | Leukocytes (mononuclear) | Males | Myeloma | Neoplasms | Incidence | Proteins | Bone marrow | Macroglobulinemia | Hematology | Cloning | Digestion | Patients | Lymphoma | Polymerase chain reaction | Lymphocytes B | Womens health | Medical prognosis | Alleles | MyD88 protein | Lymphomas | Mutation | Females | Tumors | B-cell lymphoma
Journal Article
Journal Article
[Rinshō ketsueki] The Japanese journal of clinical hematology, ISSN 0485-1439, 10/2007, Volume 48, Issue 10, pp. 1300 - 1311
Journal Article
Leukemia Research, ISSN 0145-2126, 09/2019, Volume 84, pp. 106175 - 106175
Deletion of the long arm of chromosome 20 (del(20q)) is observed in 5–10% of patients with myelodysplastic syndromes (MDS). We examined the expression of 28... 
Deletion 20q | Myelodysplastic syndromes | Common deleted region | CHROMOSOME-20 DELETIONS | ONCOLOGY | IDENTIFICATION | HEMATOLOGY | Index Medicus
Journal Article
International Journal of Hematology, ISSN 0925-5710, 6/2011, Volume 93, Issue 6, pp. 745 - 749
The aim of this retrospective study was to evaluate the toxicity profiles of dasatinib in patients with Philadelphia chromosome positive chronic myeloid... 
Dasatinib | ALL | CML | Medicine & Public Health | Hematology | Cross intolerance | Oncology | CHRONIC MYELOGENOUS LEUKEMIA | CYTOGENETIC RESPONSES | ACCELERATED-PHASE | ABL TYROSINE KINASE | BLAST CRISIS | FOLLOW-UP | RESISTANT | ACUTE LYMPHOBLASTIC-LEUKEMIA | INHIBITORS | HEMATOLOGY | Piperazines - administration & dosage | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Thiazoles - administration & dosage | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Thiazoles - therapeutic use | Thiazoles - adverse effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Antineoplastic Agents - adverse effects | Adult | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications | Retrospective Studies | Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications | Pyrimidines - administration & dosage | Piperazines - therapeutic use | Imatinib Mesylate | Piperazines - adverse effects | Hematologic Diseases - etiology | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Aged | Benzamides | Medical colleges | Safety and security measures | Oncology, Experimental | Chronic myeloid leukemia | Research | Antineoplastic agents | Antimitotic agents | Myelocytic leukemia | Genetic research | Genetic aspects | Nonlymphoid leukemia | Cross infection | Universities and colleges | Nosocomial infections | Cancer | Index Medicus
Journal Article
Journal Article
International Journal of Hematology, ISSN 0925-5710, 4/2009, Volume 89, Issue 3, pp. 332 - 341
A phase 1/2 study was conducted to assess the safety and efficacy of dasatinib in Japanese patients with chronic myelogenous leukemia (CML) or Philadelphia... 
Dasatinib | CML | Medicine & Public Health | Hematology | Imatinib intolerant | Oncology | Ph + ALL | Imatinib resistant | Ph | ALL | CHRONIC MYELOGENOUS LEUKEMIA | CYTOGENETIC RESPONSES | ACCELERATED-PHASE | EFFICACY | ABL TYROSINE KINASE | BLAST CRISIS | Ph+ ALL | MESYLATE | IMATINIB-RESISTANT | THERAPY | INHIBITOR | HEMATOLOGY | Humans | Leukemia, Myeloid, Chronic-Phase - drug therapy | Middle Aged | Antineoplastic Agents - therapeutic use | Pyrimidines - pharmacology | Thiazoles - therapeutic use | Mutation - genetics | Thiazoles - adverse effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Asian Continental Ancestry Group | Fusion Proteins, bcr-abl - genetics | Antineoplastic Agents - adverse effects | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Adult | Aged | Antineoplastic Agents - pharmacology | Thiazoles - pharmacology | Leukemia, Myeloid, Chronic-Phase - metabolism | Fusion Proteins, bcr-abl - metabolism | Leukemia, Myeloid, Chronic-Phase - genetics | Oncology, Experimental | Genetic research | Clinical trials | Genetic aspects | Chronic myeloid leukemia | Acute lymphocytic leukemia | Research | Cancer | Imatinib | Blast crisis | Acute lymphatic leukemia | pH effects | Toxicity | Index Medicus
Journal Article